Corcept Therapeutics Officer Sells Shares
Gary Charles Robb, Chief Business Officer of Corcept Therapeutics, sold 11,000 shares of common stock on January 2, 2025, at a weighted average price of $50.5047 per share, totaling $555,551. Following the transaction, Robb directly owns 20,119 shares and indirectly owns 19,330 shares through custodial accounts for his children. The sale was executed under a 10b5-1 plan.
SEC Filing:
CORCEPT THERAPEUTICS INC [ CORT ] - Form 4 - Jan. 06, 2025
Reporter Name
Robb Gary Charles
Relationship
Chief Business Officer
Type
Sell
Amount
$555,551
SEC Filing
Form 4